Lithium Quantitative Testing Drug
Vietnam·Risk Class TBYT Loại B·Atellica CH LITH_2·Siemens Healthcare Diagnostics Inc.·Registered Sep 11, 2024- Analysis ID
- 240002058/PCBB-HCM
- Submission ID
- 000.00.19.H29-240828-0041
- Product Type
- Atellica CH LITH_2
- Product Code
- 11532401
- Manufacturer
- Siemens Healthcare Diagnostics Inc.
- Authorized Representative
- CÔNG TY TNHH SIEMENS HEALTHCARE
- Intended Use
- On Atellica CH analyzer: The Atellica CH Lithium_2 (LITH_2) test is used for in vitro diagnosis in the quantification of lithium in human serum and plasma (natri heparin, kali EDTA) using the Atellica CH Analyzer. This test is used to support the monitoring of lithium therapy. On Atellica CI analyzer: The Atellica CH Lithium_2 (LITH_2) test is used for in vitro diagnosis to quantify lithium in human serum and plasma (natri heparin, kali EDTA) using the Atellica CI Analyzer. This test is used to support the monitoring of lithium therapy.
- Registration Date
- Sep 11, 2024
Companies providing products similar to "Lithium Quantitative Testing Drug"
Recently registered similar products
Access comprehensive regulatory information for Lithium Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240002058/PCBB-HCM and manufactured by Siemens Healthcare Diagnostics Inc.. The authorized representative in Vietnam is CÔNG TY TNHH SIEMENS HEALTHCARE.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Siemens Healthcare Diagnostics Inc., and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.